Cannabis Stock Plays

[Let's Roll]

$CRWG The company plans on building out WeedTracker.com into a fully-featured on-line cannabis community!

[budfoxfun]

$NWGFF .0394 turning bullish here! http://www.barchart.com/quotes/stocks/NWGFF

[budfoxfun]

$CWRG mj stock on bounce alert! http://stockcharts.com/h-sc/ui?s=crwg

[langlui]

$ETST ~ an extremely low 3.6M floater MMJ play :

Shares Outstanding 38,554,829 a/o Aug 19, 2015
Float 13.15M
Authorized Shares 75,000,000 a/o Latest

[budfoxfun]

$NWGFF .05 not much left on the ask! http://newagefarminc.com/

[Let's Roll]

In 2016, $CRWG intends to launch a crowdfunding portal at CrowdGather to assist cannabis and digital startups in procuring financing.

[budfoxfun]

$CRWG on alert .051 bottom in here! Game On: CrowdGather Revenue Jumps 74% as Insiders Accumulate http://finance.yahoo.com/news/game-crowdgather-revenue-jumps-74-141900134.html

[langlui]

CRWG going for another huge week. Impressive Earnings news released.
http://biz.yahoo.com/e/150917/crwg10-q.html

[Let's Roll]

$BICB Drug DetectionIUT Medical has a lot of different experiences in the field of drug detection. Our products in this field are IMS devices in stationary applications for particle detection in interlock and swipe tests. The Company also has a mobile device for swipe tests. The IMS-Technologies offers a new quality of sensitive measurement of narcotics. The advantage is also the separation of the single narcotics. That means every calibrated narcotic can measured alone or in mixture. The detection limit are in the lower ng range.

[Let's Roll]

$BICB Delta9 utilizes IMS, PID or GC-Column detection technologies to analyze the breath sample collected from an individual exhaling into a tube attached to the device. As the sample passes through the device, it is ionized and the resulting molecules undergo complete analysis, with the target substances detected and identified. Any resulting concentration levels are calculated and displayed on an LCD screen. Communication with an external computer or a data collection/exchange server is accomplished via a USB port. The Delta9 device is also capable of sounding an alarm once the concentration level reaches preset limits.

[Let's Roll]

$BICB CannaSens Delta9

The science behind the CannaSens Delta9 THC detection device originates in part from the proprietary technology developed by BioCube's partner in this joint venture, IUT Medical GmbH, located in Berlin, Germany. IUT is a recognized applied science leader in the field of identification and detection methodologies, with a deep knowledge of technologies such as Ion Mobility Spectroscopy (IMS), Photo Ionization Detector (PID) analyzer and Gas Chromatographic Column (GC-Column). IUT-designed systems provide on-site detection and analysis of air particles for the presence of toxic chemical compounds, warfare agents, explosives and drugs. Through a combination of its state of the art R&D facility and manufacturing capabilities, IUT continues to enhance its knowledge of these complex and important technologies, while directly marketing and selling their detection systems to customers worldwide.

Utilizing sophisticated technology, BioCube and its strategic partner, IUT Medical, have developed CannaSens Delta9, a state-of-the-art portable THC breathalyzer device. Although some early research shows there may be potential benefits in the use of medical cannabis to treat various diseases and conditions, the Company is also keenly interested in promoting public safety and the responsible use of marijuana.

[Let's Roll]

$BICB Delta9 utilizes IMS, PID or GC-Column detection technologies to analyze the breath sample collected from an individual exhaling into a tube attached to the device. As the sample passes through the device, it is ionized and the resulting molecules undergo complete analysis, with the target substances detected and identified. Any resulting concentration levels are calculated and displayed on an LCD screen. Communication with an external computer or a data collection/exchange server is accomplished via a USB port. The Delta9 device is also capable of sounding an alarm once the concentration level reaches preset limits.

[MomsSpaghetti]

$STEV - Something up their sleeve...

They have teamed with Dr. Paul Mahlberg - he obtained one of only two Drug Enforcement Administration (DEA) Schedule 1 research licenses to pursue studies on cannabis in the United States spanning a period of 33 years from 1970-2003

Stevia Corp. Unveils 30 Years of Ground Breaking Cannabis Research at Realhemp.com

http://www.prnewswire.com/news-releases/stevia-corp-unveils-30-years-of-ground-breaking-cannabis-research-at-realhempcom-529106221.html

INDIANAPOLIS, September 24, 2015 /PRNewswire/ --

Stevia Corp. (OTC: STEV) ("Stevia Corp" or the "Company"), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds, is pleased to announce that its wholly-owned subsidiary, Real Hemp LLC, has unveiled a searchable digital library consisting of more than 30 years of peer reviewed scientific research publications focused on the cannabis plant. Stevia Corp and Real Hemp Advisory Panel member, Dr. Paul Mahlberg, is the author or co-author of each publication included in the library.

The searchable research library contains some of the most important research ever published on the cannabis plant, with specific concentration on glandular trichome development. Dr Mahlberg and his colleague's research has been referenced in thousands of cannabis and hemp articles and publications over the years, including industry leading publications such as High Times Magazine. The research also resulted in some of the most important discoveries about the cannabis plant that are still applied today by some of the most successful cannabis grow operations and industrial hemp farms in the world.

For over three decades, Dr. Mahlberg was known as one of the world's leading researchers of the cannabis plant. Dr. Mahlberg obtained one of only two Drug Enforcement Administration (DEA) Schedule 1 research licenses to pursue studies on cannabis in the United States spanning a period of 33 years from 1970-2003. During that time, he accumulated one of the most extensive seed banks in the world with over 200 strains (including landrace varieties) of cannabis from worldwide sources, which were cultivated in secure greenhouses.

Dr. Mahlberg is a Professor Emeritus of Indiana University and was an active professor in the Botany department of the University until 1994 after which he continued his research on cannabis with visiting faculty and maintained his laboratory until 2003. Dr. Mahlberg received his Ph.D. in Botany from the University of California, Berkley and his M.S. and B.S. degrees in Botany from the University of Wisconsin, Madison.

George Blankenbaker, President of Stevia Corp commented, "We are fortunate to have Dr. Mahlberg on our advisory panel and it is a great honor that he chose our company to make his valuable research available to scientists, growers and consumers. At the time that Dr. Mahlberg was conducting his research, he was a pioneer in a field of study that did not have the full understanding and support of the general public, politicians and other scientists. Now that the true value of the cannabis plant is starting to be known and understood, there is considerable interest by many parties to have access to such research. We are thrilled to be able facilitate the expansion of knowledge of this important plant in support of this important industry."

The research library contains a total of 37 searchable publications that can be viewed at https://www.realhemp.com/mahlberg-cannabis-research/.

Stevia Corp and Real Hemp would like to thank the following public companies for assisting us in publicizing this searchable research library: Cannavest Corp. (CANV:OTCQN), Hemp Inc. (HEMP:PK), India Globalization Capital, Inc. (IGC:NYSE), Totally Hemp Crazy, Inc. (THCZ:PK)

[budfoxfun]

$CRWG mj news, check it out! http://www.cannabisfn.com

[fast.money]

$CRWG HOT STOCK! $CRWG has been going up on huge and increasing volume, traded above almost 19X daily average volume! Tons of buying, expect a continuation move north!

[budfoxfun]

$CRWG rsi in the power zone now, huge short squeeze here:

[fast.money]

Keep an eye on $CRWG! +52% strong close yesterday, added that to +80% last week. $CRWG is so ready to go up this week, likely for another 60-70%, IMO.

CRWG STOCK OF THE WEEK!

[budfoxfun]

$CRWG mj alert, strong buy rating! http://www.barchart.com/quotes/stocks/CRWG

[langlui]

WDRP on watch, see chart, ready for reversal.

[budfoxfun]

$CRWG 55% short yesterday, squeezeeee time to end the week!

[fast.money]

$CRWG updated video chart, must-see!! https://youtu.be/zA6dE633V4w

http://ih.advfn.com/videos/stock-chart/crwg-video-chart-9-17-15_zA6dE633V4w

[budfoxfun]

$CRWG .064 going, green out of the gates!

[fast.money]

$CRWG's revenue growth related to Mega Fame Casino (social game segment) has helped improve operating performance significantly.

[langlui]

CRWG stock is undervalued. According to YCharts ( http://ycharts.com/companies/CRWG/key_stats ), CRWG's stock is trading more than 40% below its historical valuation of $0.0872.

[budfoxfun]

$CRWG on alert fast.money .0453 volume picking up here!

[fast.money]

$CRWG Announces the Launch of a Cannabis Themed Slot Machine Game:

http://finance.yahoo.com/news/crowdgather-inc-announces-launch-weed-132000828.html

[jedijazz]

$CRWG Cheap prices at these levels Extra Link:Most recent SEC Filings
http://www.otcmarkets.com/stock/CRWG/filings

[jedijazz]

$CRWG CrowdGather, Inc. to Present at 10th Annual Singular Research Investor Conference on September 17, 2015 http://finance.yahoo.com/news/crowdgather-inc-present-10th-annual-120000239.html

[Let's Roll]

In April, CRWG acquired digital assets including WeedTracker.com, DispensaryWeed.com, and WeedInHollywood.com as part of an effort to diversify its digital assets to capitalize on the growing cannabis industry.

[budfoxfun]

$CRWG .0439 on radar! The launch of Weed in Hollywood™! The Company’s first cannabis themed social slot game. Available for download on Google Play: https://play.google.com/store/apps/details?id=com.crowdgather.winh

[budfoxfun]

$CRWG on alert this week! CrowdGather, Inc. to Present at 10th Annual Singular Research Investor Conference on September 17, 2015 http://finance.yahoo.com/news/crowdgather-inc-present-10th-annual-120000239.html

[fast.money]

$EPAZ nice news! Epazz AutoHire Subscription Renewal Rates Above 90%; AutoHire has Helped to Increase Epazz's Revenue

http://finance.yahoo.com/news/epazz-autohire-subscription-renewal-rates-121500984.html

CHICAGO, IL--(Marketwired - August 19, 2015) - Epazz, Inc. (EPAZ), a leading provider of cloud based business software solutions, announced its subscription renewal rates for AutoHire recruiting software are well over the 90% level. AutoHire has helped to increase Epazz’s revenue. AutoHire, recruiting software, continues to receive positive responses on our support and customization IT consulting services.

“We acquired AutoHire back in 2010, we have been upgrading the solution for the past two years onto the latest technologies. The new version of AutoHire is called Provitrac and will include a learn management system. Our goal for AutoHire is to create a complete human resources cloud suite,” says Shaun Passley, Ph.D., CEO of Epazz, Inc.

1. $EPAZ big earnings news! Epazz Reports 83 Percent Increase in Revenues for First Quarter of 2015

http://finance.yahoo.com/news/epazz-reports-83-percent-increase-121500054.html

CHICAGO, IL--(Marketwired - August 11, 2015) - Epazz, Inc. (EPAZ), a leading provider of cloud-based business software solutions, announced today that it has reported revenue of $461,661, compared to revenue of $252,552 for the three months ending March 31, 2015, an increase of $209,109 or 83% from the comparative period.

K9Bytes has assisted in the increase in revenue during the 1st quarter. Epazz believes increase levels of software development into the acquisitions and cross-selling to existing customers can greatly improve revenue for 2015. Epazz plans to integrate Strantin Live Video software into our K9Bytes subsidiary to allow kennels to provide live broadcast of their facilities to their customers.

“We have been experiencing substantial growth during 2015, our acquisition K9bytes will provide new sources of revenue. We believe once Strantin Live Video software is fully integrated into K9Kloud we will have a new source of revenue from monthly recurring access to the live video stream. The key to our acquisition strategy is not only maintaining and growing the target company revenue, but using our existing product portfolio to create new products,” says Shaun Passley, PhD, CEO of Epazz, Inc.

[fast.money]

$NXTD NASDAQ stock! $NXTD extremely LOW Floater! 9.1Mil in FLOAT! see latest share structure

Shares Outstanding 27,541,974 a/o Aug 12, 2015
Float 8.01M (Yahoo! Finance)
Authorized Shares 100,000,000 a/o Jun 30, 2015

[fast.money]

$CRWG now with the news of WeedTracker.com relaunch, $CRWG looks good for a bounce!! http://alturl.com/sdtcr

[budfoxfun]

$CRWG ready to go green here in power hour! http://finance.yahoo.com/news/cashing-cannabis-crowdgathers-smart-approach-120000557.html

[langlui]

DSCR Trip 000 stock has been having solid accumulation for some time now, look at the chart

http://stockcharts.com/c-sc/sc?s=DSCR&p=D&yr=1&mn=0&dy=0&i=t18707009139&r=1441165801866

[budfoxfun]

$CRWG .0539 not much left on the ask here! big mj news! http://finance.yahoo.com/news/cashing-cannabis-crowdgathers-smart-approach-120000557.html

[fast.money]

$EPAZ on Alert > to launch a revenue based crowdfunding campaign in order to fund its sales and marketing efforts.

The funds will be used to increase its sales and marketing workforce to promote its successes with implementing its cloud based solutions into new government and business customers, and also to hire more developers to enhance its cloud software applications.

[jedijazz]

$CRWG CrowdGather has Ideal Risk-Free Exposure in on-line cannabis community. $CRWG operates a growing portfolio of special interest forums and scalable multi-platform games. In April, we announced the acquisition of digital assets including WeedTracker.com, DispensaryWeed.com, and WeedInHollywood.com as part of an effort to diversify its digital assets to capitalize on the growing cannabis industry. The diversification also is consistent with our overall focus of accumulating online users and monetizing them.

While companies like GW Pharmaceuticals plc (NASDAQ:GWPH) and Cannabis Science Inc. (CBIS) are pursuing clinical trials, our business model enables them to immediately capitalize on the information component of the growing industry without relying on regulatory approvals to begin realizing revenue by providing web services to cannabis consumers and then generating revenue from advertising.

We plan on building out WeedTracker.com into a fully-featured on-line cannabis community, while turning WeedInHollywood.com into its first cannabis themed gaming title. Beyond these efforts, our management hopes to become a nexus for the entire digital cannabis movement by designing a crowdfunding platform focused on cannabis that it intends to launch on its root domain - CrowdGather.com - in early 2016.

[fast.money]

$CRWG watch, only 52M in float!! Very low share structure - see below:

Shares Outstanding 117,283,509
Float 52.17M
Authorized Shares 975,000,000

[jedijazz]

$CRWG 9/17 big announcement coming! CrowdGather, Inc. to Present at 10th Annual Singular Research Investor Conference on September 17, 2015
http://finance.yahoo.com/news/crowdgather-inc-present-10th-annual-120000239.html

[Let's Roll]

$CRWG Cashing in on Cannabis: CrowdGather’s Smart Approach to capturing value from the Industry

http://www.cannabisfn.com/cashing-in-on-cannabis-crowdgathers-smart-approach-to-capturing-value-from-the-industry/

[fast.money]

NXT-ID, Inc. (NXTD) creator of the Wocket® smart wallet, announces its new sales campaign for Q4 2015
http://stockpumpers.blogspot.com/2015/08/nxt-id-inc-launches-sales-campaign-for.html

[budfoxfun]

$CRWG company operates a growing portfolio of special interest forums and scalable multi-platform games. In April, the company announced the acquisition of digital assets including WeedTracker.com, DispensaryWeed.com, and WeedInHollywood.com as part of an effort to diversify its digital assets to capitalize on the growing cannabis industry. The diversification also is consistent with its overall focus of accumulating online users and monetizing them.

http://www.cannabisfn.com/cashing-in-on-cannabis-crowdgathers-smart-approach-to-capturing-value-from-the-industry/

[budfoxfun]

$CRWG hot cannabis news here! http://finance.yahoo.com/news/cashing-cannabis-crowdgathers-smart-approach-120000557.html

[Screech691]

$LXRP radar on news

Technology Achieves Cannabidiol Absorption Rate 499% Greater Than Baseline in Laboratory Testing [Market News Publishing (Canada)]

LEXARIA CORP

LEXARIA CORP ("LXX-Z;LXRP-0") - Technology Achieves Cannabidiol Absorption Rate 499% Greater - Than Baseline in Laboratory Testing

Lexaria, Corp. (the "Company") is very pleased to announce potential industry-changing achievements in enhanced gastro-intestinal absorption of cannabidiol (CBD) utilizing Lexaria's patent pending technology. The recent third-party testing was conducted in two phases of in vitro tests beginning in June and completed in August, 2015.

The independent laboratory results have delivered average CBD permeability of 499% of baseline permeability, compared to CBD permeability without Lexaria's technology. These results exceed Company expectations.

This was assessed in a strictly controlled, in vitro experiment using a human intestinal tissue model. Samples of Lexaria's commercially available CBD-fortified ViPova(TM) black tea were administered in the model compared with concentration-matched CBD control preparations that lacked Lexaria's patent-pending formulation and process enhancements. Lexaria believes that its in vitro findings provide compelling evidence of the intestinal absorption enhancing capabilities of its technology, based on which it is exploring opportunities to progress to more advanced, follow-on bioavailability testing in animals.

The tests also showed 325% of baseline gastro-intestinal permeability of CBD comparing Lexaria's CBD-fortified ViPova(TM) black tea to a second control of CBD and black tea combined, without Lexaria's patent-pending formulation enhancements. This confirms that the specialized processing undertaken by Lexaria during its manufacturing process together with its formulation enhancements, does indeed significantly improve absorption levels.

As previously reported by the Company, bioavailability of CBD (or of THC) varies greatly by delivery method. Smoking typically delivers cannabinoids at an average bioavailability rate of 30% (Huestis (2007) Chem. Biodivers. 4:1770-1804; McGilveray (2005) Pain Res. Manag. 10 Suppl. A:15A - 22A). By comparison, orally consumed cannabis edibles typically deliver cannabinoids at an average bioavailability rate of only 5% (Karschner et al. (2011) Clin. Chem. 57:66-75).

The Company's present findings suggest that its technology may achieve a 5-fold improvement in cannabinoid absorption in edible form over that which can be achieved without its proprietary process and formulation enhancements. This conceptually supports that Lexaria's technology represents a significant breakthrough in cannabinoid delivery by approximating the high absorption levels achieved as though through administration by smoking, but without the associated negative effects on human health caused by smoking.

"I am very pleased with the performance of our patent-pending technology in this carefully designed and controlled experiment," said John Docherty, President. "This evidences the disruptive nature of Lexaria and its technology within the cannabinoid edibles industry, and poises the Company to become a leader in the development of potentially a wide range of product lines with enhanced gastro-intestinal absorption performance capabilities."

The tests were completed in two phases culminating with testing using simulated intestinal fluid conditions that delivered these findings. These results were stronger than earlier iterations of the tests that did not use a simulated intestinal fluid environment and has contributed to Lexaria's understanding of the mechanisms at work. For these and other reasons, Lexaria believes that bioavailability testing in animals is likely to yield even stronger absorption results in the presence of natural intestinal fluid conditions.

CBD has been repeatedly found to provide beneficial pain relieving, anti-inflammatory, anti-anxiety, neuroprotection, anti-psychotic, and anti-convulsive effects among others. Lexaria's patent-pending technology could significantly reduce individual serving requirements for CBD to consumers. This could lead to reduced costs of consumption for consumers and increased profitability for Lexaria.

More detailed data from the results of the Lexaria experiments are available under strict confidentiality and non-compete agreements to potential industry partners who wish to license our proprietary technology to improve the bioavailability of key ingredients within their products while simultaneously enhancing their firm's profitability.

Lexaria also reminds stakeholders that the same technology used to enhance the absorption of CBD in the recent laboratory tests, is applicable to THC, nicotine, NSAIDs and other lipophilic compounds that are widely used today.

"We are thrilled to have generated these positive laboratory results substantiating the effectiveness of our technology," said Chris Bunka, CEO. "We believe that this only increases the likelihood of our patents being granted in due course since it demonstrates how our technology improves absorption of CBD. We have every reason to believe it will function in a similar manner if tested with THC, nicotine, or any of the other molecules named in our patent applications."

Lexaria is investigating the possibility to pursue publication of its findings in a reputable scientific journal.

About Lexaria

Lexaria is a food sciences company focused on the delivery of active compounds that can behave as superfoods through its proprietary infusion technologies. Lexaria's technology enables higher bioavailability rates for CBD; THC; NSAIDs; Nicotine and other molecules than is possible without lipophilic enhancement technology. This can allow for lower overall dosing requirements and/or higher effectiveness in active molecule delivery. Lexaria hopes to reduce other common but less healthy ingestion methods such as smoking as it embraces the benefits of public health. www.lexariaenergy.com

[fast.money]

Just on $NXTD Twitter: #BIOMETRIC #TECHNOLOGY FIRM NXT-ID SEEKS PATENT FOR #CRYPTOCURRENCY SYSTEM, COMPLETES FUNDING ROUND
https://www.cryptocoinsnews.com/biometric-technology-firm-nxt-id-seeks-patent-cryptocurrency-system-completes-funding-round/ …
#Wocket $NXTD

[budfoxfun]

$WDRP huge news alert here, bullish +40% now! http://finance.yahoo.com/news/wanderport-announces-capital-raising-stock-120200023.html

[fast.money]

$WDRP Subbie ~ daily chart ready for a bounce!

[jedijazz]

For All Your LAHO DD - Use+More http://www.pennystocktweets.com/stocks/profile/LAHO